FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210358569> ?p ?o ?g. }

• W4210358569 endingPage "2636" @default.
• W4210358569 startingPage "2619" @default.
• W4210358569 abstract "The insulin/IGF-1R/PI3K/Akt signalling cascade is increasingly being linked to breast cancer development, with aldose reductase (AR) playing a key role in mediating the crosstalk between this pathway and angiogenesis. The current study was designed to investigate whether nimbolide, a neem limonoid, targets the oncogenic signaling network to prevent angiogenesis in breast cancer.Breast cancer cells (MCF-7, MDA-MB-231), EAhy926 endothelial cells, MDA-MB-231 xenografted nude mice, and tumour tissues from breast cancer patients were used for the study. The expression of AR and key players in IGF-1/PI3K/Akt signaling and angiogenesis was evaluated by qRT-PCR, immunoblotting, and immunohistochemistry. Molecular docking and simulation, overexpression, and knockdown experiments were performed to determine whether nimbolide targets AR and IGF-1R.Nimbolide inhibited AR with consequent blockade of the IGF-1/PI3K/Akt and /HIF-1alpha/VEGF signalling circuit by influencing the phosphorylation and intracellular localisation of key signaling molecules. The downregulation of DNMT-1, HDAC-6, miR-21, HOTAIR, and H19 with the upregulation of miR-148a/miR-152 indicated that nimbolide regulates AR and IGF-1/PI3K/Akt signaling via epigenetic modifications. Coadministration of nimbolide with metformin and the chemotherapeutic drugs tamoxifen/cisplatin displayed higher efficacy than single agents in inhibiting IGF-1/PI3K/Akt/AR signaling. Grade-wise increases in IGF-1R and AR expression in breast cancer tissues underscore their value as biomarkers of progression.This study provides evidence for the anticancer effects of nimbolide in cellular and mouse models of breast cancer besides providing leads for new drug combinations. It has also opened up avenues for investigating potential molecules such as AR for therapeutic targeting of cancer." @default.
• W4210358569 created "2022-02-08" @default.
• W4210358569 creator A5008018526 @default.
• W4210358569 creator A5018164154 @default.
• W4210358569 creator A5031707536 @default.
• W4210358569 creator A5042475972 @default.
• W4210358569 creator A5047643938 @default.
• W4210358569 creator A5059039894 @default.
• W4210358569 creator A5073910932 @default.
• W4210358569 creator A5083143645 @default.
• W4210358569 creator A5090933183 @default.
• W4210358569 date "2022-08-01" @default.
• W4210358569 modified "2023-10-01" @default.
• W4210358569 title "Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling" @default.
• W4210358569 cites W1482548152 @default.
• W4210358569 cites W1571663644 @default.
• W4210358569 cites W1775749144 @default.
• W4210358569 cites W1988945136 @default.
• W4210358569 cites W2026070762 @default.
• W4210358569 cites W2061741790 @default.
• W4210358569 cites W2069261355 @default.
• W4210358569 cites W2073095285 @default.
• W4210358569 cites W2092084997 @default.
• W4210358569 cites W2096305380 @default.
• W4210358569 cites W2107684325 @default.
• W4210358569 cites W2111608472 @default.
• W4210358569 cites W2125200558 @default.
• W4210358569 cites W2145805608 @default.
• W4210358569 cites W2170853272 @default.
• W4210358569 cites W2198636128 @default.
• W4210358569 cites W2248331669 @default.
• W4210358569 cites W2281777572 @default.
• W4210358569 cites W2291435605 @default.
• W4210358569 cites W2311660610 @default.
• W4210358569 cites W2316856344 @default.
• W4210358569 cites W2416900233 @default.
• W4210358569 cites W2554335216 @default.
• W4210358569 cites W2572907409 @default.
• W4210358569 cites W2593371615 @default.
• W4210358569 cites W2593601572 @default.
• W4210358569 cites W2607666115 @default.
• W4210358569 cites W2610794842 @default.
• W4210358569 cites W2613898758 @default.
• W4210358569 cites W2614231898 @default.
• W4210358569 cites W2768839728 @default.
• W4210358569 cites W2772814183 @default.
• W4210358569 cites W2774655394 @default.
• W4210358569 cites W2802528458 @default.
• W4210358569 cites W2804421876 @default.
• W4210358569 cites W2811222943 @default.
• W4210358569 cites W2885892293 @default.
• W4210358569 cites W2896965182 @default.
• W4210358569 cites W2897204809 @default.
• W4210358569 cites W2900170069 @default.
• W4210358569 cites W2911984343 @default.
• W4210358569 cites W2915605172 @default.
• W4210358569 cites W2948065193 @default.
• W4210358569 cites W2951327248 @default.
• W4210358569 cites W2993007827 @default.
• W4210358569 cites W3012358882 @default.
• W4210358569 cites W3022246603 @default.
• W4210358569 cites W3023899890 @default.
• W4210358569 cites W3026114757 @default.
• W4210358569 cites W3026913158 @default.
• W4210358569 cites W3039967083 @default.
• W4210358569 cites W3040910136 @default.
• W4210358569 cites W3047464915 @default.
• W4210358569 cites W3087399005 @default.
• W4210358569 cites W3097532364 @default.
• W4210358569 cites W3123631538 @default.
• W4210358569 cites W3125552741 @default.
• W4210358569 cites W3128646645 @default.
• W4210358569 cites W3129637084 @default.
• W4210358569 cites W3132142311 @default.
• W4210358569 cites W3137238442 @default.
• W4210358569 cites W3159934295 @default.
• W4210358569 cites W3195563980 @default.
• W4210358569 doi "https://doi.org/10.2174/1871520622666220204115151" @default.
• W4210358569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35125086" @default.
• W4210358569 hasPublicationYear "2022" @default.
• W4210358569 type Work @default.
• W4210358569 citedByCount "3" @default.
• W4210358569 countsByYear W42103585692023 @default.
• W4210358569 crossrefType "journal-article" @default.
• W4210358569 hasAuthorship W4210358569A5008018526 @default.
• W4210358569 hasAuthorship W4210358569A5018164154 @default.
• W4210358569 hasAuthorship W4210358569A5031707536 @default.
• W4210358569 hasAuthorship W4210358569A5042475972 @default.
• W4210358569 hasAuthorship W4210358569A5047643938 @default.
• W4210358569 hasAuthorship W4210358569A5059039894 @default.
• W4210358569 hasAuthorship W4210358569A5073910932 @default.
• W4210358569 hasAuthorship W4210358569A5083143645 @default.
• W4210358569 hasAuthorship W4210358569A5090933183 @default.
• W4210358569 hasConcept C104317684 @default.
• W4210358569 hasConcept C121608353 @default.
• W4210358569 hasConcept C126322002 @default.
• W4210358569 hasConcept C127561419 @default.
• W4210358569 hasConcept C185592680 @default.

• next